Genscript Biotech Corpora... (GNNSF)

PNK: GNNSF · Real-Time Price · USD

1.30

0.00 (0.00%)

At close: Apr 29, 2025, 8:00 PM

Genscript Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	131.99M	1.45B	1.02B	1.18B	629.06M	252.4M	494.56M	123.86M	136.46M
Short-Term Investments	489.19M	481.65M	439.33M	222.23M	142.11M	174.13M	70.06M	3.09M	n/a
Long-Term Investments	3.3B	91.11M	-423.3M	-203.77M	-128.12M	-166.84M	-58.78M	-1.34M	-7.78M
Other Long-Term Assets	497.78M	189.93M	516.41M	235.37M	153.38M	181.57M	70.06M	3.09M	7.78M
Receivables	118.72M	218.83M	171.67M	142.44M	165.71M	87.87M	82.97M	255.35M	21.16M
Inventory	31.1M	53.35M	59.94M	44.36M	31.75M	19.86M	12.43M	6.88M	4.24M
Other Current Assets	54.68M	150.68M	134.89M	41.07M	43.62M	36.12M	33.53M	8.4M	2.81M
Total Current Assets	834.98M	2.35B	1.76B	1.64B	993.17M	554.05M	679.46M	397.89M	163.91M
Property-Plant & Equipment	602.84M	750.74M	646.92M	492.44M	360.54M	250.29M	179.46M	93.16M	53.7M
Goodwill & Intangibles	14.37M	20M	26.36M	65.68M	64.73M	64.65M	34.93M	3.94M	3.51M
Total Long-Term Assets	4.44B	1.05B	781.43M	594.81M	454.23M	335.37M	237.51M	106.37M	62.12M
Total Assets	5.28B	3.39B	2.55B	2.23B	1.45B	889.41M	916.98M	504.26M	226.03M
Account Payables	29.84M	39.96M	55.76M	30.18M	23.38M	17.63M	11.19M	8.15M	4.35M
Deferred Revenue	n/a	91.92M	41.64M	34.72M	84.41M	188.01M	131.73M	218.34M	7.52M
Short-Term Debt	88.75M	57.01M	33.68M	521K	44.64M	17.01M	10.5M	1.11M	48K
Other Current Liabilities	111.97M	316.12M	193.77M	235.32M	142.91M	-89.06M	-36.92M	30.79M	5.22M
Total Current Liabilities	307.34M	494.81M	545.98M	464.37M	327.91M	224.5M	153.51M	272.72M	39.22M
Long-Term Debt	17.31M	287.13M	261.01M	121.07M	1.26M	1.75M	n/a	n/a	n/a
Other Long-Term Liabilities	567.43M	432.42M	306.53M	527.03M	296.13M	n/a	4.02M	n/a	n/a
Total Long-Term Liabilities	647.57M	848.14M	637.74M	675.45M	303.9M	292.61M	270.16M	3.23M	2.8M
Total Liabilities	954.91M	1.34B	1.18B	1.14B	631.82M	517.11M	423.68M	275.94M	42.01M
Total Debt	170.57M	416.99M	349.8M	156.45M	55M	24.13M	10.5M	1.11M	48K
Common Stock	2.14M	2.12M	2.11M	2.1M	1.95M	1.88M	1.84M	1.73M	1.69M
Retained Earnings	2.35B	-632.23M	-516.04M	-309.98M	-189.37M	15.58M	112.55M	93.23M	72.03M
Comprehensive Income	n/a	56.87M	84.17M	95.42M	60.16M	25.22M	21.06M	22.96M	6.72M
Shareholders Equity	4.32B	1.39B	1.01B	879.75M	901.71M	382.8M	478.66M	217.81M	177.61M
Total Investments	3.79B	572.63M	16.03M	18.47M	13.99M	7.28M	11.28M	1.75M	-7.78M